McKenna DG

References (8)

Title : Effects of the 5-HT4 receptor agonist, cisapride, on neuronally evoked responses in human bladder, urethra, and ileum - Kullmann_2013_Auton.Neurosci_176_70
Author(s) : Kullmann FA , Kurihara R , Ye L , Wells GI , McKenna DG , Burgard EC , Thor KB
Ref : Auton Neurosci , 176 :70 , 2013
Abstract : Kullmann_2013_Auton.Neurosci_176_70
ESTHER : Kullmann_2013_Auton.Neurosci_176_70
PubMedSearch : Kullmann_2013_Auton.Neurosci_176_70
PubMedID: 23511063

Title : Epibatidine, a nicotinic acetylcholine receptor agonist, inhibits the capsaicin response in dorsal root ganglion neurons - Zhang_2001_Brain.Res_919_166
Author(s) : Zhang XF , McKenna DG , Briggs CA
Ref : Brain Research , 919 :166 , 2001
Abstract : Zhang_2001_Brain.Res_919_166
ESTHER : Zhang_2001_Brain.Res_919_166
PubMedSearch : Zhang_2001_Brain.Res_919_166
PubMedID: 11689175

Title : Gain of function mutation of the alpha7 nicotinic receptor: distinct pharmacology of the human alpha7V274T variant - Briggs_1999_Eur.J.Pharmacol_366_301
Author(s) : Briggs CA , McKenna DG , Monteggia LM , Touma E , Roch JM , Arneric SP , Gopalakrishnan M , Sullivan JP
Ref : European Journal of Pharmacology , 366 :301 , 1999
Abstract : Briggs_1999_Eur.J.Pharmacol_366_301
ESTHER : Briggs_1999_Eur.J.Pharmacol_366_301
PubMedSearch : Briggs_1999_Eur.J.Pharmacol_366_301
PubMedID: 10082212

Title : Activation and inhibition of the human alpha7 nicotinic acetylcholine receptor by agonists - Briggs_1998_Neuropharmacol_37_1095
Author(s) : Briggs CA , McKenna DG
Ref : Neuropharmacology , 37 :1095 , 1998
Abstract : Briggs_1998_Neuropharmacol_37_1095
ESTHER : Briggs_1998_Neuropharmacol_37_1095
PubMedSearch : Briggs_1998_Neuropharmacol_37_1095
PubMedID: 9833639

Title : ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization - Donnelly-Roberts_1998_J.Pharmacol.Exp.Ther_285_777
Author(s) : Donnelly-Roberts D , Puttfarcken PS , Kuntzweiler TA , Briggs CA , Anderson DJ , Campbell JE , Piattoni-Kaplan M , McKenna DG , Wasicak JT , Holladay MW , Williams M , Arneric SP
Ref : Journal of Pharmacology & Experimental Therapeutics , 285 :777 , 1998
Abstract : Donnelly-Roberts_1998_J.Pharmacol.Exp.Ther_285_777
ESTHER : Donnelly-Roberts_1998_J.Pharmacol.Exp.Ther_285_777
PubMedSearch : Donnelly-Roberts_1998_J.Pharmacol.Exp.Ther_285_777
PubMedID: 9580626

Title : ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties - Sullivan_1997_J.Pharmacol.Exp.Ther_283_235
Author(s) : Sullivan JP , Donnelly-Roberts D , Briggs CA , Anderson DJ , Gopalakrishnan M , Xue IC , Piattoni-Kaplan M , Molinari E , Campbell JE , McKenna DG , Gunn DE , Lin NH , Ryther KB , He Y , Holladay MW , Wonnacott S , Williams M , Arneric SP
Ref : Journal of Pharmacology & Experimental Therapeutics , 283 :235 , 1997
Abstract : Sullivan_1997_J.Pharmacol.Exp.Ther_283_235
ESTHER : Sullivan_1997_J.Pharmacol.Exp.Ther_283_235
PubMedSearch : Sullivan_1997_J.Pharmacol.Exp.Ther_283_235
PubMedID: 9336329

Title : A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand - Sullivan_1996_Neuropharmacol_35_725
Author(s) : Sullivan JP , Donnelly-Roberts D , Briggs CA , Anderson DJ , Gopalakrishnan M , Piattoni-Kaplan M , Campbell JE , McKenna DG , Molinari E , Hettinger AM , Garvey DS , Wasicak JT , Holladay MW , Williams M , Arneric SP
Ref : Neuropharmacology , 35 :725 , 1996
Abstract : Sullivan_1996_Neuropharmacol_35_725
ESTHER : Sullivan_1996_Neuropharmacol_35_725
PubMedSearch : Sullivan_1996_Neuropharmacol_35_725
PubMedID: 8887981

Title : Effect of MK-801 at the human alpha 7 nicotinic acetylcholine receptor - Briggs_1996_Neuropharmacol_35_407
Author(s) : Briggs CA , McKenna DG
Ref : Neuropharmacology , 35 :407 , 1996
Abstract : Briggs_1996_Neuropharmacol_35_407
ESTHER : Briggs_1996_Neuropharmacol_35_407
PubMedSearch : Briggs_1996_Neuropharmacol_35_407
PubMedID: 8793902